NutraLife BioSciences, Inc. (NLBS)

Market Cap	18.06K
Revenue (ttm)	631.96K
Net Income (ttm)	-3.99M
Shares Out	180.61M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	135,556
Open	0.0001
Previous Close	n/a
Day's Range	0.0001 - 0.0001
52-Week Range	0.0000 - 0.0003
Beta	-2.02
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About NutraLife BioSciences

NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol (CBD) products. Its CBD products include cannabinoid-rich hemp oil derived from industrial hemp; tinctures; topical lotions and oils applied directly to the skin to treat pain or inflammation; face creams; massage oils; nutraceutical sprays with CBD as an added ingredient; and pet products. The company also offers other products, such as skincare and sanitizer products. Nutra...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2010
• Employees: 12
• Stock Exchange: OTCMKTS
• Ticker Symbol: NLBS

Financial Performance

In 2021, NutraLife BioSciences's revenue was $626,619, a decrease of -50.10% compared to the previous year's $1.26 million. Losses were -$5.83 million, 101.6% more than in 2020.